Where can I find news about ABT?

The latest press releases, SEC filings, and earnings call transcripts for Abbott Laboratories (ABT) are listed on this page. Press releases come from the company's investor relations feed; filings come directly from SEC EDGAR.

Where are ABT's SEC filings?

Abbott Laboratories (ABT)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.

When was ABT's last earnings call?

The most recent earnings call transcript for Abbott Laboratories (ABT) is on this page with the full speaker-by-speaker conversation. Older quarter transcripts are also available — click any past quarter pill to load it.

ABT

Abbott Laboratories

NYSE·Medical, Devices · Healthcare

$100.59$0.92+0.92%

After hours·$100.78+0.19%

Market cap$175.21B·Market closed·Jul 22 7:59 PM UTC

Press Releases

3 Reasons to Buy AbbVie Stock Like There's No Tomorrow
It looks like a great buy-and-hold option.
fool.comJul 21, 2026 · 6:30 PM
Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Abbott Laboratories (NYSE:ABT) both recently posted earnings that show two healthcare giants moving in opposite strategic directions.
247wallst.comJul 21, 2026 · 11:00 AM
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
zacks.comJul 21, 2026 · 10:02 AM
Andra AP fonden Has $21.22 Million Stock Holdings in Abbott Laboratories $ABT
Andra AP fonden lowered its position in shares of Abbott Laboratories (NYSE: ABT) by 36.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 206,708 shares of the healthcare product maker's stock after selling 118,500 shares during the quarter.
defenseworld.netJul 21, 2026 · 4:59 AM
Abbott Laboratories $ABT Shares Sold by AlTi Global Inc.
AlTi Global Inc. lowered its stake in shares of Abbott Laboratories (NYSE: ABT) by 54.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,563 shares of the healthcare product maker's stock after selling 12,779 shares during the period. AlTi
defenseworld.netJul 21, 2026 · 3:13 AM
Ascent Wealth Partners LLC Reduces Position in Abbott Laboratories $ABT
Ascent Wealth Partners LLC reduced its stake in Abbott Laboratories (NYSE: ABT) by 29.4% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 65,255 shares of the healthcare product maker's stock after selling 27,145 shares during the quarter. Ascent Wealth
defenseworld.netJul 19, 2026 · 5:58 AM
Assetmark Inc. Boosts Holdings in Abbott Laboratories $ABT
Assetmark Inc. grew its stake in shares of Abbott Laboratories (NYSE: ABT) by 8.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 202,552 shares of the healthcare product maker's stock after purchasing an additional 16,506 shares during the period. Assetmark Inc.'s
defenseworld.netJul 19, 2026 · 5:18 AM
AIA Group Ltd Boosts Holdings in Abbott Laboratories $ABT
AIA Group Ltd grew its position in shares of Abbott Laboratories (NYSE: ABT) by 49.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 442,653 shares of the healthcare product maker's stock after purchasing an additional 147,225 shares during the
defenseworld.netJul 19, 2026 · 4:43 AM

SEC Filings

8-K
Jul 16, 2026View on SEC
11-K
Jun 18, 2026View on SEC
SD
May 27, 2026View on SEC
SC 13G
Apr 29, 2026View on SEC
10-Q
Apr 29, 2026View on SEC
8-K
Apr 27, 2026View on SEC

Transcripts

PRO

Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.

Click below to see what's inside, then upgrade to read every transcript for ABT and 80,000+ other tickers.

Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.

Frequently Asked Questions About ABT

Where can I find news about ABT?: The latest press releases, SEC filings, and earnings call transcripts for Abbott Laboratories (ABT) are listed on this page. Press releases come from the company's investor relations feed; filings come directly from SEC EDGAR.
Where are ABT's SEC filings?: Abbott Laboratories (ABT)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.
When was ABT's last earnings call?: The most recent earnings call transcript for Abbott Laboratories (ABT) is on this page with the full speaker-by-speaker conversation. Older quarter transcripts are also available — click any past quarter pill to load it.

Abbott Laboratories

Frequently Asked Questions About ABT

Abbott Laboratories

3 Reasons to Buy AbbVie Stock Like There's No Tomorrow

Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories